(MedPage Today) — WASHINGTON — Seladelpar (Livdelzi) provided sustained pruritus relief for up to 30 months in patients with primary biliary cholangitis (PBC), according to long-term data from the open-label ASSURE study.
Among participants…
Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118486
Author :
Publish date : 2025-11-12 22:10:00
Copyright for syndicated content belongs to the linked Source.
